Washington, D.C. – The Bipartisan Policy Center will host three educational forums over the next several months to inform the national conversation on affordable medicines. The purpose of these forums will be to seek an understanding of how private sector decisions and public sector policies impact the prices of drugs and their costs to the health care system. They will highlight what is known about the present system and explore the full range of viewpoints on this issue. BPC hopes each convening will explore how best to support medical innovation while ensuring access and affordability for patients.
“Pharmaceutical drugs are an essential component in the treatment of a variety of medical conditions, particularly chronic diseases,” stated BPC senior fellow and former Senate Majority Leader Bill Frist, MD. “Lowering the costs of drug development and delivery for patients, providers, payers, and the pharmaceutical industry is critical to ensure the sustainability of our health care system.”
BPC co-founder and former Senate Majority Leader Tom Daschle added, “The issue of drug costs has risen to the top of the public’s health care priorities and has also attracted bipartisan attention in Congress and in the presidential campaigns. BPC’s efforts to shed light on the current system will add clarity to the various policy discussions that are underway.”
Schedule of Forums:
How are drugs priced, re-priced, who gets what rebate, and how do payer actions impact patient access?
April 13, 2016: 10:00 – 11:30 a.m.
How do existing federal statutes and regulations impact pharmaceutical innovation, market competition, and costs?
May 10, 2016: 10:00 – 11:30 a.m.
How do pharmaceuticals fit into value-based payment and are there novel methods for financing breakthrough treatments?
June 16, 2016: 1:00 – 2:30 p.m.
Bipartisan Policy Center
1225 Eye Street NW
Washington, D.C. 20005